CUSIP 829401108 · who reports it, how much, and how much it matters to them
24 of the 720 hedge fund managers we track reported shares of Sionna Therapeutics, Inc. (Nasdaq: SION) on Form 13F for 30 June 2026. Between them they reported USD 943m. The largest position belongs to Ra Capital Management, at USD 436m.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management1 fund on PPLI.com | USD 436m | 3.8% |
| 2 | Viking Global Investors4 funds on PPLI.com | USD 141m | 0.4% |
| 3 | Orbimed Advisors1 fund on PPLI.com | USD 112m | 2.1% |
| 4 | Adage Capital Management1 fund on PPLI.com | USD 70m | 0.1% |
| 5 | Citadel Advisors32 funds on PPLI.com | USD 50m | 0.0% |
| 6 | Perceptive Advisors6 funds on PPLI.com | USD 40m | 0.6% |
| 7 | Baker Bros. Advisors2 funds on PPLI.com | USD 18m | 0.1% |
| 8 | Casdin Capital3 funds on PPLI.com | USD 18m | 0.9% |
| 9 | Millennium Management6 funds on PPLI.com | USD 12m | 0.0% |
| 10 | Artisan Partners1 fund on PPLI.com | USD 8.3m | 0.0% |
| 11 | Sofinnova Investments1 fund on PPLI.com | USD 6.4m | 0.3% |
| 12 | Sio Capital Management4 funds on PPLI.com | USD 5.6m | 0.9% |
| 13 | Artia Global Partners1 fund on PPLI.com | USD 5.3m | 1.0% |
| 14 | D. E. Shaw & Co.15 funds on PPLI.com | USD 4.5m | 0.0% |
| 15 | Rock Springs Capital Management2 funds on PPLI.com | USD 4.4m | 0.2% |
| 16 | Walleye Capital8 funds on PPLI.com | USD 4.3m | 0.0% |
| 17 | Superstring Capital Management1 fund on PPLI.com | USD 2.8m | 1.8% |
| 18 | POINT72 Asset Management17 funds on PPLI.com | USD 2.2m | 0.0% |
| 19 | Tudor Investment Corporation10 funds on PPLI.com | USD 993,000 | 0.0% |
| 20 | Engineers Gate Manager1 fund on PPLI.com | USD 686,000 | 0.0% |
| 21 | Marshall Wace LLP84 funds on PPLI.com | USD 554,000 | 0.0% |
| 22 | The Quarry1 fund on PPLI.com | USD 297,000 | 0.0% |
| 23 | Squarepoint Ops7 funds on PPLI.com | USD 238,000 | 0.0% |
| 24 | Jain Global1 fund on PPLI.com | USD 210,000 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Ra Capital Management | USD 436m | 3.8% |
| 2 | Orbimed Advisors | USD 112m | 2.1% |
| 3 | Superstring Capital Management | USD 2.8m | 1.8% |
| 4 | Artia Global Partners | USD 5.3m | 1.0% |
| 5 | Sio Capital Management | USD 5.6m | 0.9% |
| 6 | Casdin Capital | USD 18m | 0.9% |
| 7 | Perceptive Advisors | USD 40m | 0.6% |
| 8 | Viking Global Investors | USD 141m | 0.4% |
| 9 | Sofinnova Investments | USD 6.4m | 0.3% |
| 10 | Rock Springs Capital Management | USD 4.4m | 0.2% |
Sionna Therapeutics, Inc. trades under the symbol SION on the Nasdaq. Its CUSIP, the code used on Form 13F, is 829401108.
24 of the 720 hedge fund managers PPLI.com tracks reported Sionna Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Ra Capital Management (USD 436m), Viking Global Investors (USD 141m), Orbimed Advisors (USD 112m), Adage Capital Management (USD 70m) and Citadel Advisors (USD 50m).
24 managers in our coverage reported it, and between them they run 210 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Ra Capital Management, where the position was 3.8% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Sionna Therapeutics, Inc. or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.